Pharmaspectra, a global provider of medical affairs data to the pharmaceutical and biotech industries, has been acquired by IQVIA, a publicly traded US healthcare information company, at an enterprise valuation of $100 million.
Founded in 2005, Pharmaspectra is a leader in scientific dissemination data and analytics for the pharmaceutical industry. The company's extensive database includes approximately 16 million conference presentations, 28 million publication abstracts, and nearly 500,000 clinical trial results. Pharmaspectra's data is utilized by seven of the world's ten largest pharmaceutical companies. The company operates offices in the UK, USA, Switzerland, and India. The transaction valued Pharmaspectra at $100 million.
IQVIA, formerly known as Quintiles and IMS Health Inc., is an American multinational health information technology and clinical research company. IQVIA provides biopharmaceutical development and commercial outsourcing services, primarily focusing on Phase I-IV clinical trials and related laboratory and analytical services, including consulting. The company employs approximately 90,000 people in over 100 countries and has a market capitalization of around $50 billion. IQVIA is recognized as one of the largest contract research organizations globally.
Inflexion Private Equity acquired Pharmaspectra in 2019 through one of its funds. With Inflexion's support, Pharmaspectra expanded its global presence in key markets and accelerated the development of new products. Notably, Inflexion facilitated market entry into China and growth of the team in India. Over three years, targeted investments in sales, marketing, and customer service increased the company's customer base by approximately 160%.
ConAlliance is a leading M&A advisory firm specializing in comprehensive support for company sales and acquisitions within the healthcare sector. Since its founding in 2011, ConAlliance has successfully managed over 150 mandates.
ConAlliance's expertise is highly focused on corporate transactions within the healthcare sector. The firm’s core competencies include contract research organizations (CROs), healthcare IT, medical technology, medical devices, nursing care, hospitals, the pharmaceutical industry, drugs, and other manufacturing and service companies in the global healthcare industry.
For more information about ConAlliance, please visit www.conalliance.com.
The information in this article has been carefully researched; however, no liability can be accepted for the accuracy of the information provided. All information is without guarantee.